dimethyldithiocarbamate has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bronstein, JM; Casida, JE; Chesselet, MF; Chou, AP; Fernagut, PO; Fitzmaurice, AG; Klintenberg, R; Li, S; Maidment, N; Mortazavi, F | 1 |
1 other study(ies) available for dimethyldithiocarbamate and Parkinson Disease
| Article | Year |
|---|---|
Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome.
Topics: Animals; Dimethyldithiocarbamate; Dopamine; Enzyme Inhibitors; Fungicides, Industrial; Humans; Male; Mice; Neurons; Parkinson Disease; Proteasome Endopeptidase Complex; Rats; Tyrosine 3-Monooxygenase; Ubiquitin-Protein Ligases; Ziram | 2008 |